North American osteoarthritis therapeutics market is estimated to grow at a CAGR of 8.1% during the forecast period. Some pivotal factors accelerating the market growth include the rising incidences of arthritis and rising demand for viscosupplementation agents in the region. As per the Arthritis Foundation, in the US, nearly 54.4 million adults (22.7% of all adults) had doctor-diagnosed arthritis during the period, 2013-2015. By 2040, an estimated adult aged 18 years and older with doctor-diagnosed arthritis will be 78.4 million (25.9% of the estimated total adult population) in the US. Osteoarthritis is the most common kind of arthritis that can damage any joints in the hips, spine, hands, and knee. The rising geriatric population and sports injuries are some key causes for the rising incidences of osteoarthritis in the region. This, in turn, is driving the demand for osteoarthritis therapies for the treatment of the condition and pain management. 

The market is segmented based on anatomy and drug type. Based on anatomy, the market is classified into the knee, ankle, hip, hand, and spine. Knee osteoarthritis is one of the key causes of disability in the US. The condition develops slowly, and the pain worsens with time. Viscosupplementation is one of the therapies used for knee osteoarthritis treatment. Hyaluronic acid (viscosupplementation) is a naturally occurring lubricant that facilitates the smoother movement of joints. Hyaluronic acid is found in fewer concentrations in knee osteoarthritis patients.  Based on drug type, the market is segmented into NSAIDs, viscosupplementation agents, corticosteroids, and analgesics. 

Some key players in the market include Pfizer Inc., Bayer AG, Zimmer Biomet Holdings, Inc., Sanofi S.A., and GlaxoSmithKline plc. Rising FDA approvals for osteoarthritis treatment have been witnessed over the years. For instance, in February 2020, GlaxoSmithKline plc declared the US FDA approval of Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID). It is an arthritis pain relief available as an OTC product to temporarily provide relief from arthritis pain in the knee, elbow, hand, ankle, wrist, or foot, in adults (18 years and older).  The approval of the US FDA has made it the first and only prescription-strength, NSAID topical gel for arthritis pain available OTC in the US. This approval will offer approximately 30 million Americans suffering from osteoarthritis OTC access to the topical treatment option.

Research Methodology

The market study of the North American osteoarthritis therapeutics market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. North American Osteoarthritis Therapeutics Market Research and Analysis by Anatomy
2. North American Osteoarthritis Therapeutics Market Research and Analysis by Drug Type

The Report Covers

• Comprehensive research methodology of the North American osteoarthritis therapeutics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.Analysis of regional regulations and other government policies impacting the North American osteoarthritis therapeutics market.
• Insights about market determinants which are stimulating the North American osteoarthritis therapeutics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.